Open AccessRanibizumab in patients with dense cataract and proliferative diabetic retinopathy with rubeosis
Author(s) -
Neelakshi Bhagat,
Yufei Tu,
Catherine Fay,
Suqin Guo,
Marco A. Zarbin,
Edward Marcus
Publication year - 2012
Publication title -
oman journal of ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.306
H-Index - 16
eISSN - 0974-7842
pISSN - 0974-620X
DOI - 10.4103/0974-620x.106099
Subject(s) - medicine , ranibizumab , diabetic retinopathy , cataract surgery , ophthalmology , adverse effect , choroidal neovascularization , surgery , retinal , bevacizumab , diabetes mellitus , chemotherapy , endocrinology
To evaluate the safety of ranibizumab as a surgical adjunct during cataract surgery in patients with proliferative diabetic retinopathy (PDR) with rubeosis, and to evaluate the efficacy and adverse effects of ranibizumab in treating PDR with rubeosis.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom